BioCentury
ARTICLE | Financial News

Aldeyra raises $28.8M follow-on

September 22, 2017 7:55 PM UTC

Aldeyra Therapeutics Inc. (NASDAQ:ALDX), which focuses on diseases related to aldehydes, raised $28.8 million through the sale of 4 million shares at $7.25 in a follow-on underwritten by Cantor Fitzgerald and Laidlaw. The price is a 20% discount to Aldeyra’s close of $9.10 on Sept. 18 when it proposed the offering after market hours. The figures include the sale of a 517,500 overallotment on Sept. 21...

BCIQ Company Profiles

Aldeyra Therapeutics Inc.